Understanding Androgenetic Alopecia
Androgenetic alopecia is a common type of hair loss found worldwide. Hair follicle function declines gradually as genetic and hormonal factors interact. The goal of treatment is not to restore every lost hair, but to evaluate the follicles that still retain function and determine a direction for management. Early diagnosis and ongoing management matter.
Androgenetic alopecia (AGA) includes male pattern hair loss (MPHL) and female pattern hair loss (FPHL) (Devjani Shivali et al., 2023). They share the same biological mechanism, but their clinical presentations differ considerably.
The Role of DHT and Follicle Miniaturization
Dihydrotestosterone (DHT) drives the core mechanism. In scalp follicles, testosterone converts to DHT through the action of 5α-reductase. Type II 5α-reductase is mainly responsible, but type I enzyme, found in structures such as the scalp's sebaceous glands, also plays a partial role. When DHT binds to androgen receptors on follicle cells, the miniaturization process begins. Follicles that once produced thick, long hair gradually shift to producing thin, short, vellus-like hair.
This change progresses slowly over several years. At first, it may only feel like the hair is getting a bit thinner. The reduction in hair shaft diameter begins well before hair density visibly decreases.
Male pattern hair loss follows a pattern in which the frontal hairline recedes or the crown becomes exposed (Nestor Mark S et al., 2021). Female pattern hair loss more often involves diffuse thinning centered on the crown while the hairline stays intact. Though the hormonal mechanism is the same, differing hormonal environments produce different clinical presentations.
If a follicle has not yet completely lost function, treatment can be considered. Even when function has declined, as long as living follicles remain, a treatment direction can still be set. So the timing should not be missed.
Causes and Risk Factors of Androgenetic Alopecia
No single cause accounts for hair loss. Genetic predisposition, hormonal changes, and environmental factors interact to produce it (Devjani Shivali et al., 2023).
Genetic Predisposition
There's a common saying that if your maternal grandfather was bald, you will go bald too, but this is only half true. Genes linked to androgenetic alopecia are scattered across multiple chromosomes, not just the X chromosome. Risk passes down through both the paternal and maternal lines. A father with severe hair loss may not pass it on to his children, and a person can develop hair loss even when no one on the maternal side had it.
The Effect of Hormonal Changes
Hormonal changes trigger this genetic predisposition. After puberty, rising testosterone increases DHT levels, and follicle miniaturization can begin from that point. After menopause, declining estrogen lets androgen effects become relatively stronger, and the incidence of FPHL rises (Nestor Mark S et al., 2021). Postpartum hair loss occurs regardless of AGA predisposition, but when an AGA predisposition is present, it can be more pronounced or last longer. Thyroid dysfunction triggers or worsens hair loss through separate mechanisms.
Stress and Lifestyle Factors
Chronic stress is a risk factor that cannot be ignored. Animal studies report that cortisol may suppress hair follicle stem cell activity and shorten the growth phase. Clinical evidence in humans remains limited so far. A sudden, heavy shedding of hair two to three months after a major stressful event can also occur. This corresponds to stress-induced telogen effluvium. When AGA is present, the two processes can progress together.
Nutritional status matters. Deficiencies in iron, biotin, zinc, or vitamin D can slow hair growth. Excessive dieting or insufficient protein intake also weakens hair. Seborrheic dermatitis or scalp inflammation places additional burden on follicles that are already weakened.
Identifying the cause of hair loss requires looking at how genetics overlap with a person's current hormonal environment and lifestyle factors. That's why the cause is analyzed before treatment begins.
Hair Loss Progression Stages and Diagnostic Criteria
If you suspect hair loss, check what stage you're currently in. Judging by feeling alone can cause you to miss the right window for treatment or lead to unnecessary anxiety.
Classification Systems
Clinically, male pattern hair loss is classified into Hamilton-Norwood stages I–VII, and female pattern hair loss into Ludwig stages I–III (Nestor Mark S et al., 2021). The Hamilton-Norwood scale is based on the degree of frontal hairline recession and the extent of crown hair loss, while the Ludwig scale evaluates hair density reduction centered on the crown. This classification serves as the practical basis for determining treatment direction.
Diagnostic Tools and Methods
Trichoscopy, or hair dermoscopy, evaluates hair shaft diameter variability, perifollicular inflammation, and other dermoscopic findings. It can help detect follicular miniaturization that isn't visible to the naked eye. Quantifying hair count per unit area with hair density measurement equipment can be useful for monitoring treatment progress.
Blood tests can also help with diagnosis. For female pattern hair loss, clinicians check a hormone panel—testosterone, DHEAS, and thyroid hormone—along with nutritional markers such as serum ferritin, vitamin D, and zinc. If thyroid dysfunction, anemia, or a nutritional deficiency is driving the hair loss, that should be corrected first.
The Importance of Early Diagnosis
Many people first seek care only after reaching Hamilton-Norwood stage III–IV or later. Treatment can still be considered at this stage, but the fewer follicles that remain, the narrower the range of results you can expect. It's better to get diagnosed when you notice your hair thinning and changing in thickness, rather than waiting until hair loss becomes visibly noticeable.
The diagnostic results determine whether to start medication, combine it with regenerative treatment, or whether you've reached a stage where hair transplantation should be considered.
Treatment Options for Androgenetic Alopecia
Treatment for androgenetic alopecia falls into two categories — medication and regenerative therapy — and the two approaches aren't competitors. Clinicians combine them according to the stage of hair loss.
Medication
Topical minoxidil is an FDA-approved treatment for hair loss (Gupta A K et al., 2022). The 5% formulation is used for male pattern hair loss, while the FDA has approved the 2% solution and 5% foam for female pattern hair loss. Since the 5% liquid formulation was originally approved for men, it's important to check with your doctor about the approved scope and suitability by sex and formulation. Applied directly to the scalp, minoxidil is reported to be involved in extending the hair growth phase (anagen) through several mechanisms, including vasodilation, anti-inflammatory action, and induction of the Wnt/β-catenin signaling pathway. Shedding sometimes increases temporarily early in treatment, which is sometimes interpreted as part of the hair cycle resetting. If symptoms persist or scalp irritation is severe, see a doctor.
Oral finasteride inhibits type II 5-alpha reductase, reducing DHT production (Nestor Mark S et al., 2021). It may help slow the progression of hair loss. Prescribing it is restricted for patients who may become pregnant, because of the risk of fetal malformation. Some sexual side effects have also been reported in men, so doctors should explain these fully before prescribing.
Dutasteride inhibits both type I and type II 5-alpha reductase. It's reported to suppress DHT over a broader range, but that doesn't mean it's more suitable in every case. Its side effects are reviewed together with this.
Beyond FDA-approved treatments, there's low-level laser therapy (LLLT, cleared by the FDA as a 510(k) medical device). Oral and topical agents, hormone therapy, supplements, and hair transplantation are each reviewed within the categories of medication, adjunct therapy, and surgical treatment (Nestor Mark S et al., 2021). Low-dose oral minoxidil is also discussed as one of the treatment options, and whether it suits a given patient should be confirmed with their doctor. Response to medication and side-effect patterns vary from person to person.
Regenerative Therapy
When medication alone has limits, regenerative therapy is discussed as a complementary option. PRP therapy concentrates platelets from the patient's own blood and injects them into the scalp. There are reports that growth factors in platelets may be involved in regulating the environment around hair follicles.
Exosome-based therapy is being studied on the premise that it may use cell-to-cell signaling molecules to act on hair follicle regeneration pathways. Neither Korea's Ministry of Food and Drug Safety nor the FDA has formally approved it as a hair loss treatment, and it remains at the research stage. Some small-scale pilot studies have suggested a response, but large-scale randomized controlled trials are still lacking (Devjani Shivali et al., 2023). For this reason, it is considered for patients who have had an insufficient response to medication and PRP, after checking scalp inflammation and the condition of remaining follicles.
PDRN (polydeoxyribonucleotide) is a substance whose use is discussed on the premise that it may be involved in scalp tissue regeneration and inflammation-related pathways. It is considered together with other options when chronic scalp inflammation is present, and whether to use it is decided based on diagnostic results and the individual's condition. Response to regenerative therapy varies from person to person.
Principles of Combining Treatments
The right combination of treatments depends on the stage of hair loss, sex, overall health, and lifestyle. In early stages, treatment may start with topical minoxidil alone; when progression is rapid or the response to medication is insufficient, oral medication is combined with regenerative therapy. Which combination is appropriate is decided based on diagnostic findings.
What You Can Realistically Expect from Hair Loss Treatment
When people start hair loss treatment, what they hope for most is that the hair they lost will grow back. Honestly, that's hard to make the main goal.
The goal of treating androgenetic alopecia is to preserve the function of hair follicles that are still alive now, with partial recovery as a possible additional outcome. A follicle that has already lost function completely is difficult to restore with medication or regenerative treatment. The follicles that respond to treatment are the ones still shrinking — follicles whose function has declined but that haven't died completely. This is why the initial evaluation matters so much.
Timeline of Treatment Response
Judging the treatment response takes at least 3 to 6 months of observation, because the hair growth cycle runs on a scale of several months. After starting minoxidil, some people notice temporarily more hair shedding. This is explained as resting-phase hairs falling out first, before they move into the growth phase.
The Reality of Relapse After Stopping Treatment
Stopping treatment can cause the response that had been maintained to disappear (Devjani Shivali et al., 2023). Some studies report that when hair density was maintained during medication use, hair loss can resume within several months after stopping (Gupta A K et al., 2022). This, too, varies by individual. Treating androgenetic alopecia is not like taking antibiotics for a set period and being done. Maintaining the response requires ongoing management. It's worth being clear about this before starting treatment.
The Limits and Role of Hair Transplantation
Hair transplantation is a surgical procedure that fills in areas where hair has already been lost. The transplant itself does not block the effect of DHT. So even after a transplant, the surrounding hair that wasn't transplanted may keep falling out. This is why medication and regenerative treatment are considered alongside transplantation, to support graft survival and manage the surrounding hair.
The Nature of Treatment
Hair loss treatment isn't something finished in a single session. Managing it while follicles are still alive can help slow the progression of hair loss, depending on the individual's condition. The response varies from person to person. Whatever treatment someone chooses, that decision starts with accurately knowing the current state of their own follicles.
M-shaped Hair Loss and Scalp Circulation: Why Neck and Shoulder Tension Often Show Up Together
M-shaped hair loss, where the hairline recedes on both sides of the forehead, is mainly caused by hormones and genetics. Still, among people showing this pattern, the muscles at the back of the neck and across the upper shoulders are frequently tight as well. Blood flow heading up to the scalp passes between the neck and upper shoulder muscles on its way to the scalp's surface layer. If this pathway stays compressed for a long time, the response to medication applied to the scalp or to regenerative treatment performed on the scalp varies from session to session.
Neck and shoulder tension is not the cause of this type of hair loss. When we evaluate how far it has progressed and how well treatment is working, we also check for tightness in the neck and upper shoulder muscles along with the scalp itself. If photos taken under the same lighting and angle at 3-month intervals are available, we base the assessment on those changes. Without photos, judging by feel alone makes it hard to separate how far the hairline has receded from changes in crown density.
References
- Devjani Shivali, Ezemma Ogechi, Kelley Kristen J (2023). Androgenetic Alopecia: Therapy Update.. Drugs. PMID: 37166619
- Nestor Mark S, Ablon Glynis, Gade Anita (2021). Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.. J Cosmet Dermatol. PMID: 34741573
- Gupta A K, Talukder M, Venkataraman M (2022). Minoxidil: a comprehensive review.. J Dermatolog Treat. PMID: 34159872
Frequently Asked Questions
How does androgenetic alopecia differ from what people usually call "ordinary" hair loss?
Androgenetic alopecia is a chronic process in which DHT-driven hair follicle miniaturization progresses slowly over several years. Telogen effluvium, often referred to as "ordinary hair loss," is different. It occurs when temporary factors such as severe stress, nutritional deficiency, or childbirth push growth-phase hairs into the resting phase all at once. Because it often resolves naturally once the triggering factor is addressed, its prognosis differs from androgenetic alopecia, which requires long-term management.
Will hair loss come back if I stop the medication?
The biological cause of androgenetic alopecia does not go away on its own, so stopping the medication can allow DHT to resume shrinking the hair follicles, and hair loss may start progressing again. The medication only works while it is actively "maintaining" follicle function. Whether to continue treatment is a decision you make together with your doctor, based on your current hair condition and your overall health.
Can women develop androgenetic alopecia too?
Female pattern hair loss (FPHL) falls within the category of androgenetic alopecia, and the same DHT pathway seen in men is involved. In women, however, the hairline is often preserved while hair density decreases diffusely over the crown, a pattern that visually distinguishes it from male pattern hair loss. There are also reports of symptoms becoming more pronounced after menopause, as declining estrogen levels increase the relative influence of androgens.
Can I stop taking medication after a hair transplant?
The donor-area follicles used in hair transplants have relatively high resistance to DHT, and this resistance generally persists after transplantation. However, a transplant does not stop the progression of androgenetic alopecia, so the existing follicles outside the transplanted area continue to be affected. For this reason, continuing medication alongside the transplant to manage the remaining follicles is generally recommended.
When Is the Best Time to Start Treatment?
Starting treatment before hair follicles lose function completely — while they are still in the miniaturization stage — allows for a higher maintainable hair density. Because hair loss progresses over several years, the point when you feel "it hasn't fallen out that much yet" may actually be the window where treatment response is better. Checking the stage of progression objectively is important before deciding when to start treatment.
This content is provided for medical information purposes only and may vary depending on individual conditions. Please consult a specialist for accurate diagnosis and treatment.